Bullish Options Positioning Continues in Nektar Therapeutics (NKTR) -Susquehanna
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Join SI Premium – FREE
Susquehanna options strategist Alison Edwards notes bullish options positioning in Nektar Therapeutics (NASDAQ: NKTR), as an opening investor bought 2k Jan 50 Calls for $3.15, adding to prior purchases this week of May and Jan2019 calls.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Assumes Nektar Therapeutics (NKTR) at Buy
- NVIDIA (NVDA) 10K contracts of September 125 puts trade
- Popular stocks with increasing option volume: SPCX MSTR PLTR MU HOOD MRNA SOFI BABA INTC WMT
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Susquehanna International Group of CompaniesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
